Connect your AI

DaVita DVA Reportable Legal Entities — Intangible Assets Net Excluding Goodwill

Discontinued — last reported Q1 '18

Similar metrics at other companies

RSReportable Legal Entities — Intangible Assets Net Excluding Goodwill

$1.06B—

CLHReportable Legal Entities — Intangible Assets Net Excluding Goodwill

$407.89M-5.0%

CDWReportable Legal Entities — Intangible Assets Net Excluding Goodwill

$388.6M-26.7%

BALLReportable Legal Entities — Intangible Assets Net Excluding Goodwill

$93M—

STLDReportable Legal Entities — Intangible Assets Net Excluding Goodwill

$265.48M—

TPX

TPXReportable Legal Entities — Intangible Assets Net Excluding Goodwill

——

Other financials

Income statement

Revenue$3.4B+6.0%

Operating income$481.9M+9.8%

Net income$197.5M+21.2%

EPS (diluted)$2.87+43.5%

Balance sheet

Cash & equivalents$726.4M+38.5%

Total debt$13.3B+6.7%

Total equity-$755.5M-183%

Total assets$17.5B+2.2%

Cash flow

Operating cash flow$320.8M+78.2%

CapEx$102.0M-28.8%

Free cash flow$218.8M+495%

Valuation

Market cap$13.34B-16.0%

Enterprise value$25.95B-5.5%

P/E17.1×-1.4×

P/S1×-0.3×

Profitability

Operating margin15.1%-0.7pp

Net margin5.6%-1.0pp

FCF margin10.8%-2.8pp

Returns & leverage

Return on equity159.1%+80.9pp

Debt / equity103.6×+92.8×

Current ratio1.4×+0.2×

Where this comes from

Reported directly by DaVita in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: DaVita’s 10-Q, filed May 3, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does reportable legal entities — intangible assets net excluding goodwill mean?: The net book value of non-physical assets like patents and licenses, excluding goodwill.
How do you interpret reportable legal entities — intangible assets net excluding goodwill?: Higher values suggest significant investment in intellectual property or strategic acquisitions of intangible rights.
How does reportable legal entities — intangible assets net excluding goodwill compare across companies?: High for healthcare firms with significant proprietary clinical software or specialized service contracts.